PATENT CLAIM ANALYSIS

Application Number: 16024558
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates a method wherein a molecule is used for inducing and/or promoting skipping of at least one of exon 43, exon 46, exons 50-53 of the DMD pre-mRNA in a patient, preferably in an isolated cell of a patient, the method comprising providing said cell and/or said patient with a molecule. The invention also relates to said molecule as such.

Claim (Index 13):
The isolated antisense oligonucleotide of  claim 1 , said oligonucleotide being RNA.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 94.0
- Lexical Diversity: 1.61905
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15468239', '12605276', '12992218', '14248279', '15428385']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7770176480385289
- 35 USC 102 Novelty (BERT): 0.5380777736097055
- Combined Prediction Score: 0.7531236605956466
- Mean Citation Score: 367.672316
- Max Citation Score: 377.07214
- Similarity Product: 316.22460089936374

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test